Abstract
Current guidelines recommend chemotherapy with or without radiotherapy for induction therapy in selected patients with stage IIIA non-small cell lung cancer (NSCLC).1 However national practice patterns vary with strong institutional preference for either neoadjuvant chemotherapy or neoadjuvant chemoradiation (NCR). A challenging subset of patients with locally advanced NSCLC are those likely to require complex resection and reconstruction or pneumonectomy. Because of significant short-term and long-term advantages, sleeve resection is preferred over pneumonectomy when possible.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
